Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,440.00
-20.00 (-0.37%)
At close: Jun 27, 2025, 3:30 PM KST

Meta Biomed Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
22,41922,40210,0802,6289,522-4,093
Upgrade
Depreciation & Amortization
4,9774,9814,2233,8603,5713,941
Upgrade
Loss (Gain) From Sale of Assets
-778.630.91-12.62-1,212-1,16095.87
Upgrade
Asset Writedown & Restructuring Costs
--1,015487.37541.234,661
Upgrade
Loss (Gain) From Sale of Investments
-401.67-349.53-90.29-53.65-51.16260.6
Upgrade
Loss (Gain) on Equity Investments
-1,196-1,181-682.88-373.09-537.62-468.69
Upgrade
Provision & Write-off of Bad Debts
443.06444.66-158.44-172.39-1,3768.39
Upgrade
Other Operating Activities
-330.82-1,451-2,9262,115-1,63757.12
Upgrade
Change in Accounts Receivable
-1,858593.08186.61-1,024-171.242,190
Upgrade
Change in Inventory
-116.73-2,514-470.44926.992,038-1,989
Upgrade
Change in Accounts Payable
-1,569-807.66304.0593.14-1,503-513.05
Upgrade
Change in Other Net Operating Assets
123.74513.17-1,2511,8841,900712
Upgrade
Operating Cash Flow
21,71122,63310,2179,15911,1364,862
Upgrade
Operating Cash Flow Growth
43.61%121.52%11.55%-17.75%129.06%69.70%
Upgrade
Capital Expenditures
-7,446-10,914-11,489-15,395-2,067-2,227
Upgrade
Sale of Property, Plant & Equipment
133.0961.83128.067.451,4136.53
Upgrade
Cash Acquisitions
----2,295-2.45-
Upgrade
Divestitures
----535.01-
Upgrade
Sale (Purchase) of Intangibles
-188.6-188.9-5.4385.95-33.29-824.5
Upgrade
Investment in Securities
-11,551-32,4211,116-167.96,349-7,464
Upgrade
Other Investing Activities
3,24098.4-1,4513,186130593.94
Upgrade
Investing Cash Flow
-15,812-43,363-11,701-14,5786,324-9,915
Upgrade
Long-Term Debt Issued
-60,70011,37537,0831,94916,759
Upgrade
Long-Term Debt Repaid
--36,544-11,940-27,828-17,827-5,123
Upgrade
Net Debt Issued (Repaid)
-5,73024,156-565.379,255-15,87811,635
Upgrade
Repurchase of Common Stock
-140.74-140.74--63.26--
Upgrade
Dividends Paid
-684.93-457.42-457.42-458.02-229.01-232.67
Upgrade
Other Financing Activities
20-148-0-00
Upgrade
Financing Cash Flow
-6,53623,410-1,0238,734-16,10711,403
Upgrade
Foreign Exchange Rate Adjustments
-556.651,04177.02-201.36121.38-60.48
Upgrade
Miscellaneous Cash Flow Adjustments
00--00-
Upgrade
Net Cash Flow
-1,1933,721-2,4303,1131,4746,288
Upgrade
Free Cash Flow
14,26611,719-1,271-6,2369,0692,634
Upgrade
Free Cash Flow Growth
17151.62%---244.28%-
Upgrade
Free Cash Flow Margin
14.38%12.46%-1.53%-9.04%15.43%5.85%
Upgrade
Free Cash Flow Per Share
499.21432.22-55.59-272.48396.00114.32
Upgrade
Cash Interest Paid
2,0342,0942,1761,259733.311,278
Upgrade
Cash Income Tax Paid
241.44163.5780379.03357.43293.62
Upgrade
Levered Free Cash Flow
1,7396,742-3,338-6,1755,6501,895
Upgrade
Unlevered Free Cash Flow
4,2749,081-1,891-5,3066,3662,527
Upgrade
Change in Net Working Capital
4,326-4,4391,246-2,790-1,607-66.21
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.